Eli Lilly and Co. this month launched a public awareness campaign called Brain Health Matters, which features actress ...

Ag giant Corteva Agriscience is reportedly mulling a split of its seed and pesticide businesses, a move that could alter the ...

Now, it’s worth noting Stock Advisor’s total average return is 1,058% — a market-crushing outperformance compared to 189 % ...

Plus, solar cars, Meta’s new glasses and AI financial agents, in this edition of The Future of Everything newsletter.

The Silvant Large Cap Growth SMA returned +18.62% (gross)/+17.74% (net) for the quarter, outperforming the Russell 1000 ...

With a market cap of $708 billion, Eli Lilly isn't far from becoming the first trillion-dollar healthcare company.

None of that happened. So if you're a long-term investor who's willing to take on some risk, Viking Therapeutics is a pharma ...

New research shows that that the diabetes/obesity medication tirzepatide can cause clinically meaningful improvements in ...

Lilly’s cardiovascular outcomes trial is the first to use an active comparator, finding noninferiority but not superiority of ...

Wegovy maker Novo Nordisk has cut a U.S. sales team focused on obesity and diabetes education for healthcare providers, ...

Eli Lilly and Co. (NYSE: LLY) is one of the best beginner stocks to buy, according to analysts. On September 17, the company ...

Pharmaceutical companies are racing to develop a GLP-1 weight-loss drug in pill form. Novo Nordisk says its oral semaglutide pill led to "significant weight loss" in a trial.